Keyword: Thermo Fisher

Thermo Fisher to buy viral vector maker Brammer Bio for $1.7B

Monday, March 25, 2019

Thermo Fisher Scientific has moved to acquire viral vector developer and manufacturer Brammer Bio for $1.7 billion in cash.

Thermo Fisher halting some China sales after DNA sweep reports

by Conor Hale

Friday, February 22, 2019

Thermo Fisher halted DNA sequencer sales in western China after reports the genetic sequencers were used to power a state DNA surveillance program.

Laser optics can rapidly assess vaccine infectivity: study

by Conor Hale

Wednesday, September 12, 2018

Engineers at LumaCyte and Thermo Fisher demonstrated rapid analysis of viral vaccines using a combination of optics and microfluidics.

1 Year Later – Why did Thermo Fisher Scientific acquire Patheon?

Thermo Fisher, Pluristem link up to industrialize cell therapies

by Conor Hale

Monday, July 9, 2018

Pluristem and Thermo Fisher will collaborate to scale up manufacturing of regenerative medicines, to build an industry capable of millions of doses.

Merck, Pfizer power tumor profiling firm Strata to $26M round

by Nick Paul Taylor

Thursday, May 24, 2018

Raising the cash sets Strata up to file for approval of a tumor molecular profiling assay while building out its platform.

Thermo, Biocept team up to pitch liquid biopsy service to pharma

by Nick Paul Taylor

Friday, March 30, 2018

The partners will validate the use of Thermo's Oncomine at Biocept’s laboratory before pitching diagnostic testing services to biopharma companies.

Blueprint, Thermo Fisher sign companion diagnostic deal

by Nick Paul Taylor

Wednesday, November 1, 2017

The deal will see Thermo Fisher validate and seek approval for a test to identify RET fusions in non-small cell lung cancer patients.

Heartflow's noninvasive CAD test covered in California, Alabama—News of Note

by Amirah Al Idrus

Friday, September 1, 2017

Here's Friday's medtech news of note.

5. Siemens Healthineers

by Amirah Al Idrus

Siemens rebranded its healthcare business in May 2016 as Siemens Healthineers. Thermo Fisher’s real-time PCR technology, Neo New Oncology and Conworx Technology are among its purchases for the year.